High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia
Daisuke Tomizawa(National Center For Child Health and Development), Souichi Adachi(Kyoto University), Kiminori Terui(Hirosaki University), Asahito Hama(Nagoya University), Hidefumi Hiramatsu(Kyoto University), Jun Matsubayashi(Tokyo Medical University), Kazutoshi Koike(Ibaraki Children's Hospital), Keizo Horibe(National Hospital Organization), Takashi Taga(Erasmus MC), Takao Deguchi(Mie University), Katsuyoshi Koh(Saitama Children's Medical Center), Yuka Iijima‐Yamashita(Nagoya Medical Center), Shin‐ichi Tsujimoto(Yokohama City University), Daisuke Hasegawa(Icahn School of Medicine at Mount Sinai), Hayato Miyachi(Tokai University), Nobutaka Kiyokawa(National Center For Child Health and Development), Yoshiko Hashii(The University of Osaka), Shiro Tanaka(University of Tokyo Health Sciences), Yuki Yuza(Tokyo Metropolitan Children's Medical Center), Daiichiro Hasegawa(Kobe Children's Hospital), Tomohiko Taki(Kyorin University), Hiroshi Moritake(University of Miyazaki), Yasushi Noguchi(Japanese Red Cross Narita Hospital), Akiko Saito(Nagoya University Hospital), Shotaro Iwamoto(Mie University)
Cited by 8
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
|Nature Genetics|2016|473